|
1
|
Wang C, Liao Y, Wang S, Tian H, Huang M, Dong XY, Shi L, Li YQ, Sun JH, Du JB, Jin HF. Guidelines for the diagnosis and treatment of neurally mediated syncope in children and adolescents (revised 2024). World J Pediatr 2024; 20:983-1002. [PMID: 39110332 PMCID: PMC11502568 DOI: 10.1007/s12519-024-00819-w] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/18/2024] [Accepted: 05/17/2024] [Indexed: 10/25/2024]
Abstract
BACKGROUND Significant progress has been made in the diagnosis and treatment of pediatric syncope since the publication of the "2018 Chinese Pediatric Cardiology Society (CPCS) guideline for diagnosis and treatment of syncope in children and adolescents" ("2018 Edition Guidelines"). Therefore, we have revised and updated it to assist pediatricians in effectively managing children with syncope. DATA SOURCES According to the "2018 Edition Guidelines", the expert groups collected clinical evidence, evaluated preliminary recommendations, and then organized open-ended discussions to form the recommendations. This guideline was developed by reviewing the literature and studies in databases including PubMed, Cochrane, EMBASE, China Biomedical Database, and Chinese Journal Full-text Database up to April 2024. Search terms included "syncope", "children", "adolescents", "diagnosis", and "treatment." RESULTS The guidelines were based on the latest global research progress and were evidence-based. The classification of syncope etiology, diagnostic procedures, postural tests, such as the active standing test, head-up tilt test, and active sitting test, clinical diagnosis, and individualized treatment for neurally mediated syncope in pediatric population were included. CONCLUSIONS The guidelines were updated based on the latest literature. The concepts of sitting tachycardia syndrome and sitting hypertension were introduced and the comorbidities of neurally mediated syncope were emphasized. Some biomarkers used for individualized treatment were underlined. Specific suggestions were put forward for non-pharmacological therapies as well as the follow-up process. The new guidelines will provide comprehensive guidance and reference for the diagnosis and treatment of neurally mediated syncope in children and adolescents.
Collapse
Affiliation(s)
- Cheng Wang
- Department of Pediatric Cardiovasoloy, Children's Medical Center, The Second Xiangya Hospital, Central South University, Changsha, 410011, China
| | - Ying Liao
- Department of Pediatrics, Peking University First Hospital, Beijing, 100034, China
| | - Shuo Wang
- Department of Pediatrics, Xiangya Hospital, Central South University, Changsha, 410008, China
| | - Hong Tian
- Department of Pediatric Cardiology, Children's Hospital of Fudan University, Shanghai, 201102, China
| | - Min Huang
- Department of Pediatric Cardiology, Shanghai Children's Hospital, Shanghai, 201102, China
| | - Xiang-Yu Dong
- Department of Pediatrics, Lanzhou University Second Hospital, Lanzhou, 730020, China
| | - Lin Shi
- Department of Pediatric Cardiology, Capital Institute of Pediatrics, Beijing, 100020, China
| | - Ya-Qi Li
- Department of Pediatric Cardiology, Capital Institute of Pediatrics, Beijing, 100020, China
| | - Jing-Hui Sun
- Department of Pediatrics, Jilin University First Hospital, Changchun, 130021, China
| | - Jun-Bao Du
- Department of Pediatrics, Peking University First Hospital, Beijing, 100034, China.
| | - Hong-Fang Jin
- Department of Pediatrics, Peking University First Hospital, Beijing, 100034, China.
- State Key Laboratory of Vascular Homeostasis and Remodeling, Peking University, Beijing, 100191, China.
| |
Collapse
|
|
2
|
Wang S, Peng Y, Wang Y, Li F, Xu Y, Zheng H, Yuan H, Hu C, Liao D, Cai H, Zhang J, Li W, Ding Y, Zhang W, Xue X, Liu X, Zhu L, Liu D, Kang M, Liu L, Chu W, Li X, Luo X, Zou R, Wang C. Relationship between syncopal symptoms and head-up tilt test modes. Cardiol Young 2024; 34:1583-1588. [PMID: 38577783 DOI: 10.1017/s1047951124000726] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 04/06/2024]
Abstract
OBJECTIVE Head-up tilt test (HUTT) is an important tool in the diagnosis of pediatric vasovagal syncope. This research will explore the relationship between syncopal symptoms and HUTT modes in pediatric vasovagal syncope. METHODS A retrospective analysis was performed on the clinical data of 2513 children aged 3-18 years, who were diagnosed with vasovagal syncope, from Jan. 2001 to Dec. 2021 due to unexplained syncope or pre-syncope. The average age was 11.76 ± 2.83 years, including 1124 males and 1389 females. The patients were divided into the basic head-up tilt test (BHUT) group (596 patients) and the sublingual nitroglycerine head-up tilt test (SNHUT) group (1917 patients) according to the mode of positive HUTT at the time of confirmed pediatric vasovagal syncope. RESULTS (1) Baseline characteristics: Age, height, weight, heart rate (HR), systolic blood pressure (SBP), diastolic blood pressure (DBP), and composition ratio of syncope at baseline status were higher in the BHUT group than in the SNHUT group (all P < 0.05). (2) Univariate analysis: Age, height, weight, HR, SBP, DBP, and syncope were potential risk factors for BHUT positive (all P < 0.05). (3) Multivariate analysis: syncope was an independent risk factor for BHUT positive, with a probability increase of 121% compared to pre-syncope (P<0.001). CONCLUSION The probability of BHUT positivity was significantly higher than SNHUT in pediatric vasovagal syncope with previous syncopal episodes.
Collapse
Affiliation(s)
- Shuo Wang
- Department of Pediatrics, Xiangya Hospital, Central South University, Changsha, China
- Department of Pediatric Cardiovasology, Children's Medical Center, The Second Xiangya Hospital, Central South University, Changsha, China
| | - Yali Peng
- Section of Science and Education, The First People's Hospital of Changde City, Changde, China
| | - Yuwen Wang
- Department of Pediatric Cardiovasology, Children's Medical Center, The Second Xiangya Hospital, Central South University, Changsha, China
| | - Fang Li
- Department of Pediatric Cardiovasology, Children's Medical Center, The Second Xiangya Hospital, Central South University, Changsha, China
| | - Yi Xu
- Department of Pediatric Cardiovasology, Children's Medical Center, The Second Xiangya Hospital, Central South University, Changsha, China
| | - Huifen Zheng
- Department of Pediatric Cardiovasology, Children's Medical Center, The Second Xiangya Hospital, Central South University, Changsha, China
- Department of Pediatrics, Shenzhen People's Hospital, Shenzhen, China
| | - Heli Yuan
- Department of Pediatric Cardiovasology, Children's Medical Center, The Second Xiangya Hospital, Central South University, Changsha, China
- Department of Pediatrics, North China University of Science and Technology Affiliated Hospital, Tangshan, China
| | - Chunyan Hu
- Department of Pediatric Cardiovasology, Children's Medical Center, The Second Xiangya Hospital, Central South University, Changsha, China
- Department of Pediatrics, The Second Affiliated Hospital, University of South China, Hengyang, China
| | - Donglei Liao
- Department of Pediatrics, Xiangya Hospital, Central South University, Changsha, China
- Department of Pediatric Cardiovasology, Children's Medical Center, The Second Xiangya Hospital, Central South University, Changsha, China
| | - Hong Cai
- Department of Pediatric Cardiovasology, Children's Medical Center, The Second Xiangya Hospital, Central South University, Changsha, China
| | - Juan Zhang
- Department of Pediatric Cardiovasology, Children's Medical Center, The Second Xiangya Hospital, Central South University, Changsha, China
| | - Wen Li
- Department of Pediatric Cardiovasology, Children's Medical Center, The Second Xiangya Hospital, Central South University, Changsha, China
| | - Yiyi Ding
- Department of Pediatric Cardiovasology, Children's Medical Center, The Second Xiangya Hospital, Central South University, Changsha, China
- Department of Pediatrics, The First People's Hospital of Changde City, Changde, China
| | - Wenhua Zhang
- Department of Pediatric Cardiovasology, Children's Medical Center, The Second Xiangya Hospital, Central South University, Changsha, China
- Department of Pediatrics, The Third Hospital of Changsha, Changsha, China
| | - Xiaohong Xue
- Department of Pediatric Cardiovasology, Children's Medical Center, The Second Xiangya Hospital, Central South University, Changsha, China
- Department of Pediatrics, Hunan Want Want Hospital, Changsha, China
| | - Xiaoyan Liu
- Department of Pediatric Cardiovasology, Children's Medical Center, The Second Xiangya Hospital, Central South University, Changsha, China
- Department of Pediatrics, Changsha Central Hospital, University of South China, Changsha, China
| | - Liping Zhu
- Department of Pediatric Cardiovasology, Children's Medical Center, The Second Xiangya Hospital, Central South University, Changsha, China
- Department of Neonatology, Changsha Central Hospital, University of South China, Changsha, China
| | - Deyu Liu
- Department of Pediatric Cardiovasology, Children's Medical Center, The Second Xiangya Hospital, Central South University, Changsha, China
- Department of Pediatrics, Hunan Lixian People's Hospital, Changde, China
| | - Meihua Kang
- Department of Pediatric Cardiovasology, Children's Medical Center, The Second Xiangya Hospital, Central South University, Changsha, China
- Department of Pediatrics, Weijia Pediatric Hospital, Changsha, China
| | - Liping Liu
- Department of Pediatric Cardiovasology, Children's Medical Center, The Second Xiangya Hospital, Central South University, Changsha, China
- Department of Pediatric Cardiology, Hunan People's Hospital/First Affiliated Hospital of Hunan Normal University, Changsha, China
| | - Weihong Chu
- Department of Pediatric Cardiovasology, Children's Medical Center, The Second Xiangya Hospital, Central South University, Changsha, China
- Department of Pediatrics, The First Affiliated Hospital, Zhengzhou University, Zhengzhou, China
| | - Xiaoming Li
- Department of Pediatric Cardiovasology, Children's Medical Center, The Second Xiangya Hospital, Central South University, Changsha, China
- Department of Pediatrics, Jieyang People's Hospital, Jieyang, China
| | - Xuemei Luo
- Department of Pediatric Cardiovasology, Children's Medical Center, The Second Xiangya Hospital, Central South University, Changsha, China
| | - Runmei Zou
- Department of Pediatric Cardiovasology, Children's Medical Center, The Second Xiangya Hospital, Central South University, Changsha, China
| | - Cheng Wang
- Department of Pediatric Cardiovasology, Children's Medical Center, The Second Xiangya Hospital, Central South University, Changsha, China
| |
Collapse
|
|
3
|
Du X, Tao C, Wang Y, Sun Y, Zhang Q, Zhang C, Liu P, Wang Y, Liao Y, Du J, Jin H. Twenty-Four-Hour Urinary Sodium Excretion Predicts Therapeutic Effectiveness of Oral Rehydration Saline in Pediatric Vasovagal Syncope. CHILDREN (BASEL, SWITZERLAND) 2022; 9:992. [PMID: 35883976 PMCID: PMC9321383 DOI: 10.3390/children9070992] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 05/19/2022] [Revised: 06/24/2022] [Accepted: 06/27/2022] [Indexed: 11/29/2022]
Abstract
The study was designed to explore whether 24-hour urinary sodium excretion could predict the therapeutic effectiveness of oral rehydration saline in pediatric cases of vasovagal syncope. Eighty children suffering from vasovagal syncope with oral rehydration saline treatment in Department of Pediatrics, Peking University First Hospital, China, were recruited into the study. They were followed up for 3 (2, 3) months after treatment. Pre-treatment demographic, clinical, head-up tilt test-based hemodynamic and laboratory variables were compared between responders and non-responders. After univariate analysis, variables with p value < 0.05 in the comparison between responders and non-responders were further analyzed by binary logistic regression analysis. Receiver operating characteristic (ROC) curve was conducted to assess the value in predicting effectiveness of oral rehydration saline treatment. The results showed that 33 cases were responders, and 47 were non-responders. Blood sodium (138 ± 2 mmol/L vs. 139 ± 2 mmol/L, p < 0.05) and pre-treatment 24-hour urinary sodium excretion (74 ± 29 mmol/24 h vs. 109 (93, 141) mmol/24 h, p < 0.001) were lower in responders than in non-responders. The baseline 24-hour urinary sodium excretion was positively correlated to the duration from tilting to the positive response appearance in head-up tilt test (r = 0.289, p < 0.01). The cut-off value of baseline 24-hour urinary sodium excretion of the therapeutic effectiveness of oral rehydration saline on vasovagal syncope cases was 83 mmol/24 h, yielding a sensitivity of 87% and a specificity of 73% with AUC of 0.842 (p < 0.001). In conclusion, 24-hour urinary sodium excretion could be a useful biomarker to predict the therapeutic response to oral rehydration saline in pediatric cases of vasovagal syncope.
Collapse
Affiliation(s)
- Xiaojuan Du
- Department of Pediatrics, Peking University First Hospital, Beijing 100034, China; (X.D.); (C.T.); (Y.W.); (Y.S.); (Q.Z.); (C.Z.); (P.L.); (Y.W.); (J.D.)
| | - Chunyan Tao
- Department of Pediatrics, Peking University First Hospital, Beijing 100034, China; (X.D.); (C.T.); (Y.W.); (Y.S.); (Q.Z.); (C.Z.); (P.L.); (Y.W.); (J.D.)
| | - Yaru Wang
- Department of Pediatrics, Peking University First Hospital, Beijing 100034, China; (X.D.); (C.T.); (Y.W.); (Y.S.); (Q.Z.); (C.Z.); (P.L.); (Y.W.); (J.D.)
| | - Yan Sun
- Department of Pediatrics, Peking University First Hospital, Beijing 100034, China; (X.D.); (C.T.); (Y.W.); (Y.S.); (Q.Z.); (C.Z.); (P.L.); (Y.W.); (J.D.)
| | - Qingyou Zhang
- Department of Pediatrics, Peking University First Hospital, Beijing 100034, China; (X.D.); (C.T.); (Y.W.); (Y.S.); (Q.Z.); (C.Z.); (P.L.); (Y.W.); (J.D.)
| | - Chunyu Zhang
- Department of Pediatrics, Peking University First Hospital, Beijing 100034, China; (X.D.); (C.T.); (Y.W.); (Y.S.); (Q.Z.); (C.Z.); (P.L.); (Y.W.); (J.D.)
| | - Ping Liu
- Department of Pediatrics, Peking University First Hospital, Beijing 100034, China; (X.D.); (C.T.); (Y.W.); (Y.S.); (Q.Z.); (C.Z.); (P.L.); (Y.W.); (J.D.)
| | - Yuli Wang
- Department of Pediatrics, Peking University First Hospital, Beijing 100034, China; (X.D.); (C.T.); (Y.W.); (Y.S.); (Q.Z.); (C.Z.); (P.L.); (Y.W.); (J.D.)
| | - Ying Liao
- Department of Pediatrics, Peking University First Hospital, Beijing 100034, China; (X.D.); (C.T.); (Y.W.); (Y.S.); (Q.Z.); (C.Z.); (P.L.); (Y.W.); (J.D.)
| | - Junbao Du
- Department of Pediatrics, Peking University First Hospital, Beijing 100034, China; (X.D.); (C.T.); (Y.W.); (Y.S.); (Q.Z.); (C.Z.); (P.L.); (Y.W.); (J.D.)
- Key Laboratory of Molecular Cardiovascular Sciences, Ministry of Education, Beijing 100191, China
| | - Hongfang Jin
- Department of Pediatrics, Peking University First Hospital, Beijing 100034, China; (X.D.); (C.T.); (Y.W.); (Y.S.); (Q.Z.); (C.Z.); (P.L.); (Y.W.); (J.D.)
| |
Collapse
|